论文部分内容阅读
目的:对于防治消化道出血使用泮托拉唑在治疗急危重症患者中是否有效研究分析方法:我院消化内科科选取67例于2012年2月~2012年8月间治疗急危重症消化道出血患者,67例患者分为两组各标记为观察组与对照组,同时给予止血抗炎、吸氧补液、纠正电解质失衡等常规治疗,7d为一疗程。观察组在常规治疗下使用静脉注射泮托拉唑注射液,对照组常规治疗下静脉注射雷尼替丁注射液,护人员详细记录两组患者出血量情况。结果:使用泮托拉唑患者总有效率为94.3%,使用雷尼替丁患者总有效率为72.3%。疗效结果存在显著性差异(P<0.05)。结论泮托拉唑在预防性治疗急危重症患者消化道出血方面效果突出,值得在临床上应用和推广。
Objective: The prevention and treatment of gastrointestinal bleeding with pantoprazole in the treatment of critically ill patients is effective in the analysis and analysis: 67 cases selected in our hospital Department of Gastroenterology in February 2012 ~ August 2012 treatment of critically ill digestive tract Bleeding patients, 67 patients were divided into two groups marked for the observation group and the control group, while giving hemostatic anti-inflammatory, oxygen infusion, electrolyte imbalance correction and other conventional treatment, 7d for a course of treatment. The observation group received routine intravenous injection of pantoprazole injection, while the control group received intravenous ranitidine injection. The nurses carefully recorded the amount of bleeding in both groups. Results: The total effective rate was 94.3% in patients receiving pantoprazole, and 72.3% in patients receiving ranitidine. Efficacy results there is a significant difference (P <0.05). Conclusion Pantoprazole is effective in the prevention and treatment of gastrointestinal bleeding in critically ill patients and is worthy of clinical application and promotion.